Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Fujisawa

Showing results (261-270 of 724) with videos related to

Pageof 73
Sort By:
Urologic Oncology|September 27, 2008
Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Toshifumi Kurahashi, Atsushi Takenaka, et al.
The Journal of Urology|September 23, 2014
Histological study of the cavernous nerve mesh outside the periprostatic region: anatomical basis for erectile function after nonnerve sparing radical prostatectomyNobuyuki Hinata, Gen Murakami, Hideaki Miyake, et al.
Targeted Oncology|October 29, 2015
Changes in Renal Function of Patients with Metastatic Renal Cell Carcinoma During Treatment with Molecular-Targeted AgentsHideaki Miyake, Mototsugu Muramaki, Satoshi Imai, et al.
Targeted Oncology|September 6, 2015
Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in JapanHideaki Miyake, Akira Miyazaki, Satoshi Imai, et al.
BJU International|March 16, 2006
Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resectionHideaki Miyake, Isao Hara, Kazuki Yamanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 1, 2023
Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment-naïve metastatic renal cell carcinomaKen-Ichi Harada, Hideaki Miyake, Junya Furukawa, et al.
Urology|January 26, 2005
Variation in course of cavernous nerve with special reference to details of topographic relationships near prostatic apex: histologic study using male cadaversAtsushi Takenaka, Gen Murakami, Akio Matsubara, et al.
Urologia Internationalis|August 5, 2006
The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese menHideaki Miyake, Iori Sakai, Taka-Aki Inoue, et al.
International Urology and Nephrology|November 4, 2006
Significance of radical cystectomy for bladder cancer in patients over 80 years oldKazuki Yamanaka, Hideaki Miyake, Isao Hara, et al.
International Journal of Clinical Oncology|November 19, 2011
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Yuji Kusuda, Ken-ichi Harada, et al.
Pageof 73

Showing results (261-270 of 724) with videos related to

Sort By:
Pageof 73
Urologic Oncology|September 27, 2008
Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Toshifumi Kurahashi, Atsushi Takenaka, et al.
The Journal of Urology|September 23, 2014
Histological study of the cavernous nerve mesh outside the periprostatic region: anatomical basis for erectile function after nonnerve sparing radical prostatectomyNobuyuki Hinata, Gen Murakami, Hideaki Miyake, et al.
Targeted Oncology|October 29, 2015
Changes in Renal Function of Patients with Metastatic Renal Cell Carcinoma During Treatment with Molecular-Targeted AgentsHideaki Miyake, Mototsugu Muramaki, Satoshi Imai, et al.
Targeted Oncology|September 6, 2015
Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in JapanHideaki Miyake, Akira Miyazaki, Satoshi Imai, et al.
BJU International|March 16, 2006
Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resectionHideaki Miyake, Isao Hara, Kazuki Yamanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 1, 2023
Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment-naïve metastatic renal cell carcinomaKen-Ichi Harada, Hideaki Miyake, Junya Furukawa, et al.
Urology|January 26, 2005
Variation in course of cavernous nerve with special reference to details of topographic relationships near prostatic apex: histologic study using male cadaversAtsushi Takenaka, Gen Murakami, Akio Matsubara, et al.
Urologia Internationalis|August 5, 2006
The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese menHideaki Miyake, Iori Sakai, Taka-Aki Inoue, et al.
International Urology and Nephrology|November 4, 2006
Significance of radical cystectomy for bladder cancer in patients over 80 years oldKazuki Yamanaka, Hideaki Miyake, Isao Hara, et al.
International Journal of Clinical Oncology|November 19, 2011
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Yuji Kusuda, Ken-ichi Harada, et al.
Pageof 73